FDA — authorised 17 December 2004
- Application: NDA021583
- Marketing authorisation holder: PFIZER
- Local brand name: DEPO-SUBQ PROVERA 104
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
🇺🇸 Depo-subQ 104 in United States
FDA authorised Depo-subQ 104 on 17 December 2004
Marketing authorisation
Frequently asked questions
Is Depo-subQ 104 approved in United States?
Yes. FDA authorised it on 17 December 2004.
Who is the marketing authorisation holder for Depo-subQ 104 in United States?
PFIZER holds the US marketing authorisation.